Brain endothelial cell expression of SPARCL-1 is specific to chronic multiple sclerosis lesions and is regulated by inflammatory mediators in vitro.

MLA

Bridel, C., et al. “Brain Endothelial Cell Expression of SPARCL-1 Is Specific to Chronic Multiple Sclerosis Lesions and Is Regulated by Inflammatory Mediators in Vitro.” Neuropathology & Applied Neurobiology, vol. 44, no. 4, June 2018, pp. 404–16. EBSCOhost, https://doi.org/10.1111/nan.12412.

APA

Bridel, C., Koel, S. M. J. A., Peferoen, L., Derada Troletti, C., Durieux, S., Gorter, R., Nutma, E., Gami, P., Iacobaeus, E., Brundin, L., Kuhle, J., Vrenken, H., Killestein, J., Piersma, S. R., Pham, T. V., De Vries, H. E., Amor, S., Jimenez, C. R., & Teunissen, C. E. (2018). Brain endothelial cell expression of SPARCL-1 is specific to chronic multiple sclerosis lesions and is regulated by inflammatory mediators in vitro. Neuropathology & Applied Neurobiology, 44(4), 404–416. https://doi.org/10.1111/nan.12412

Chicago

Bridel, C., Simmelink, M. J. A. Koel, L. Peferoen, C. Derada Troletti, S. Durieux, R. Gorter, E. Nutma, et al. 2018. “Brain Endothelial Cell Expression of SPARCL-1 Is Specific to Chronic Multiple Sclerosis Lesions and Is Regulated by Inflammatory Mediators in Vitro.” Neuropathology & Applied Neurobiology 44 (4): 404–16. doi:10.1111/nan.12412.